Mass Serialization and Traceability Implementation in the Pharma Industry Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland What drives the industry towards more “traceability” Strategic thinking & a long-term vision required Roche's roadmap A few Take-home messages An ongoing focus towards more control & security in todays’ global Pharma Supply Chains The Importance of Packaging is Increasing in Pharma Global Supply Chain Regulators Customers Brand Protection SC visibility & Control Threats / Challenges External drivers Internal drivers counterfeits Product security diversion theft Patient safety bed-side scanning avoid medication error through Barcoding & a 5 patient’s rights safer Product Identification mobile computing authentication Process integrity chain of custody / accountability & Transaction protect industry reputation combat re-imbursement fraud security supply chain visibility with Traceability at Sales trust Unit level recall effectiveness E-supply-chain & m-health / e-services Digitization e-leaflet mobile computing authentication as a transformational and sales unit level data (payers) sustainable trend 3 An ongoing focus towards more control & security in todays’ global Pharma Supply Chains The Importance of Packaging is Increasing in Pharma Global Supply Chain Regulators Customers Brand Protection SC visibility & Control Threats / Challenges External drivers Internal drivers Product security MAH’s responsibility: Increase Confidence & Patient safety Demonstrate evidence that product is safe & secure from through Barcoding & a safer Product Identification manufacturing till it reaches the patient Process integrity & Transaction security Building in intelligence and sophisticated features into with Traceability at Sales Unit level primary & secondary packaging E-supply-chain & “Interactive” packaging Digitization “intelligent” packaging as a transformational and sustainable trend 4 The outcome: the sales units gets unique and tamper-proof A unique number to identify each single tamper-proof sales pack Roche is global GS1 member new new N Serial Number Material Number O • A unique number assigned I GTIN / NTIN T to a single unit A Z • A randomized numeric code I L A I R E S d n new a Data Carrier G N Machine readable I D O Overt/Covert Anti- C Counterfeiting features - D 2 : 1 l e v Tamper Evidence e Human Readable L Information 5 What drives the industry towards more traceability Strategic thinking & a long-term vision required Roche's roadmap A few Take-home messages Strategic thinking & a long-term vision Vision ideal state Roche approach: Maximize Biz. Value Vision + backward planning 2016 3 e c n a m Ramp-Up/ Deploy ro 2013 f re 2 P e s EU VPD ir Proof-of-concept p r 2010 e t 1 n E Korea SER la TE … t o T Brazil T&T E-pedigree What we didn’ t want: 2009 «Classical» Incremental French approach Coding Think BIG Start SMALL Scale FAST 7 Where do we see this journey going… Do not focus on one specific requirement; Instead, put in perspective From Product Security… … to Transaction Security & Digitization E-services Traceability IV l III e Serialization v e M- services l tn Technical Secure e-Supply Chain e II m security t s e v measures & Tamper Evidence n I The country maps indicate what the country targets as of today I < 2010 2015 2020 8 Strategic thinking & a long-term vision What our approach is from beginning • A cross functional global effort ensure standardization, interoperability and integration Strong global drive & close cooperation with local implementation teams / SME’s This is not only a technical project • Develop and implement an adaptable/scalable technical standard solution Co-develop with vendor A constant mix of prototyping, conceptual design and operational implementation • Work together with other stakeholders authorities, standard bodies, associations, peers, trading partners, vendors… Accept the challenge as an opportunity Success through a collaborative approach 9 What drives the industry towards more traceability Strategic thinking & a long-term vision required Roche's roadmap A few Take-home messages
Description: